(Q34719096)

4 August 2017

1 reference

title

Steroid-free immunosuppression in kidney transplantation: an editorial review (English)

1 reference

4 August 2017

1 reference

kidney transplantation

1 reference

Donald E Hricik

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

American Journal of Transplantation

4 August 2017

published in

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

19-24

1 reference

Incidence and long-term cost of steroid-related side effects after renal transplantation

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Anti-inflammatory actions of steroids: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

Corticosteroid withdrawal after renal transplantation in the cyclosporin era: timing, benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

Evidence that glucocorticosteroid-mediated immunosuppressive effects do not involve altering second messenger function

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

A controlled trial of steroids in cyclosporine-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

Withdrawal of steroids after renal transplantation--clinical predictors of outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2002.020105.X

7 January 2021

10.1034/J.1600-6143.2002.020105.X

Identifiers

DOI

1 reference

4 August 2017

1 reference